Comparison 12. Intravenous midazolam versus intravenous lorazepam.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Seizure cessation | 1 | 80 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.98 [0.91, 1.04] |
2 Time from drug administration to stopping of seizures | 1 | 80 | Mean Difference (IV, Fixed, 95% CI) | 1.5 [‐9.37, 12.37] |
3 Additional dose of the trial drug required to stop seizures | 1 | 80 | Risk Ratio (M‐H, Fixed, 95% CI) | 3.0 [0.13, 71.51] |
4 Seizure recurrence within 24 hours | 1 | 80 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.0 [0.15, 6.76] |